Yoon M, Hong N, Ha J, Lee C, Ku C, Rhee Y
Hypertens Res. 2022; 45(9):1418-1429.
PMID: 35681044
DOI: 10.1038/s41440-022-00948-7.
Yugar-Toledo J, Modolo R, Faria A, Moreno H
Vasc Health Risk Manag. 2017; 13:403-411.
PMID: 29081661
PMC: 5652936.
DOI: 10.2147/VHRM.S138599.
Kim S, Ahn J, Hong H, Choi H, Kim Y, Kim N
Korean J Intern Med. 2014; 29(2):217-25.
PMID: 24648805
PMC: 3956992.
DOI: 10.3904/kjim.2014.29.2.217.
Fagugli R, Taglioni C
Int J Hypertens. 2011; 2011:162804.
PMID: 21837271
PMC: 3151507.
DOI: 10.4061/2011/162804.
Acelajado M, Calhoun D
Int J Hypertens. 2011; 2011:837817.
PMID: 21331160
PMC: 3034938.
DOI: 10.4061/2011/837817.
Primary aldosteronism: rare bird or common cause of secondary hypertension?.
Stowasser M
Curr Hypertens Rep. 2001; 3(3):230-9.
PMID: 11353574
DOI: 10.1007/s11906-001-0045-3.
Primary aldosteronism.
Gordon R
J Endocrinol Invest. 1995; 18(7):495-511.
PMID: 9221268
DOI: 10.1007/BF03349761.
[The possibility of stimulation and suppression of renin secretion by sodium deprivation and sodium loading in primary and renal hypertension].
Klaus D, Bocskor A, Fleischer K, Simsch A
Klin Wochenschr. 1970; 48(17):1024-33.
PMID: 5523457
DOI: 10.1007/BF01497207.
[Plasma renin activity in hypertensions under stimulatory and suppressive conditions].
MEURER K, Scheck K, Kaufmann W
Klin Wochenschr. 1970; 48(5):275-84.
PMID: 5523220
DOI: 10.1007/BF01486436.
[Hypertension and aldosteronism in solitary adenomas and nodular hyperplasia of the adrenal cortex].
Distler A, Barth C, Roscher S, Vecsei P, Dhom G, Wolff H
Klin Wochenschr. 1969; 47(13):688-95.
PMID: 5382548
DOI: 10.1007/BF01881618.
[Hypermineralocorticoidism and hypertension].
Wolff H, Abdelhamid S
Klin Wochenschr. 1971; 49(6):293-306.
PMID: 4932028
DOI: 10.1007/BF01496448.
[Studies on the autonomy of aldosterone secretion in primary hyperaldosteronism. Diagnosis and differential diagnosis of "Conn's syndrome"].
Helber A, Kaufmann W, MEURER K, Steiner B, Durr F, Euchenhofer M
Klin Wochenschr. 1973; 51(8):404-10.
PMID: 4715391
DOI: 10.1007/BF01468089.
[Suppression and stimulation of plasma renin concentration in primary hyper-aldosteronism].
Beckerhoff R, Wilkinson R, Luetscher J, Vetter W, Siegenthaler W
Klin Wochenschr. 1972; 50(16):783-6.
PMID: 4341810
DOI: 10.1007/BF01490305.
[Regulation of the renin-angiotensin system in congestive heart failure: indications for a total body sodium-dependent regulation of the renin secretion].
Krause D, Rosskamp E, MEURER K, Kaufmann W
Klin Wochenschr. 1972; 50(6):311-26.
PMID: 4338644
DOI: 10.1007/BF01485179.
Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
Collins R, Weinberger M, Dowdy A, NOKES G, Gonzales C, Luetscher J
J Clin Invest. 1970; 49(7):1415-26.
PMID: 4317384
PMC: 322615.
DOI: 10.1172/JCI106359.
Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
Wisgerhof M, Brown R
J Clin Invest. 1978; 61(6):1456-62.
PMID: 659608
PMC: 372671.
DOI: 10.1172/JCI109065.
[Plasma renin activity, plasma volume extracellular fluid volume and cardiac output in essential hypertension (author's transl)].
Haux R, Abholz H, Gotzen R, Schwab M
Klin Wochenschr. 1979; 57(7):319-29.
PMID: 439783
DOI: 10.1007/BF01476562.
Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
Baxter J, Schambelan M, Matulich D, Spindler B, Taylor A, Bartter F
J Clin Invest. 1976; 58(3):579-89.
PMID: 182723
PMC: 333216.
DOI: 10.1172/JCI108504.
The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
Williams G, Braley L, UNDERWOOD R
J Clin Invest. 1976; 58(1):221-9.
PMID: 180059
PMC: 333173.
DOI: 10.1172/JCI108453.
Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.
Taylor A, Mitchell J, Bartter F, Snodgrass W, McMurtry R, GILL Jr J
J Clin Invest. 1978; 62(1):162-8.
PMID: 149141
PMC: 371749.
DOI: 10.1172/JCI109101.
